These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 11158872)

  • 1. Acute metabolic effects of dialysis fluids during CAPD.
    Delarue J; Maingourd C
    Am J Kidney Dis; 2001 Jan; 37(1 Suppl 2):S103-7. PubMed ID: 11158872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of icodextrin and glucose-containing solutions on insulin resistance in CAPD patients.
    Gürsu EM; Ozdemir A; Yalinbas B; Gürsu RU; Canbakan M; Güven B; Atasoyu EM; Keskin AT; Elçi A; Baru Y
    Clin Nephrol; 2006 Oct; 66(4):263-8. PubMed ID: 17063993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of amino acid based dialysate on peritoneal blood flow and permeability in stable CAPD patients: a potential role for nitric oxide?
    Douma CE; de Waart DR; Struijk DG; Krediet RT
    Clin Nephrol; 1996 May; 45(5):295-302. PubMed ID: 8738660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of insulin and amino acids on glucose and leucine metabolism in CAPD patients.
    Castellino P; Luzi L; Giordano M; Defronzo RA
    J Am Soc Nephrol; 1999 May; 10(5):1050-8. PubMed ID: 10232692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of an amino acid dialysate on leucine metabolism in continuous ambulatory peritoneal dialysis patients.
    Delarue J; Maingourd C; Objois M; Pinault M; Cohen R; Couet C; Lamisse F
    Kidney Int; 1999 Nov; 56(5):1934-43. PubMed ID: 10571805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous ambulatory peritoneal dialysis (CAPD) of children with amino acid solutions: technical and metabolic aspects.
    Canepa A; Perfumo F; Carrea A; Piccardo MT; Ciardi MR; Cantaluppi A; Gusmano R
    Perit Dial Int; 1990; 10(3):215-20. PubMed ID: 2094461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of icodextrin on insulin resistance and adipocytokine profiles in patients on peritoneal dialysis.
    Takeguchi F; Nakayama M; Nakao T
    Ther Apher Dial; 2008 Jun; 12(3):243-9. PubMed ID: 18503703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucose oxidation after a peritoneal and an oral glucose load in dialyzed patients.
    Delarue J; Maingourd C; Lamisse F; Garrigue MA; Bagros P; Couet C
    Kidney Int; 1994 Apr; 45(4):1147-52. PubMed ID: 8007585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The haemodynamic and metabolic effects of hypertonic-glucose and amino-acid-based peritoneal dialysis fluids.
    Selby NM; Fialova J; Burton JO; McIntyre CW
    Nephrol Dial Transplant; 2007 Mar; 22(3):870-9. PubMed ID: 17121785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Six-month overnight administration of intraperitoneal amino acids does not improve lean mass.
    Maurer O; Saxenhofer H; Jaeger P; Casez JP; Descoeudres C; Horber FF
    Clin Nephrol; 1996 May; 45(5):303-9. PubMed ID: 8738661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of oral glucose on intermediary metabolism in continuous ambulatory peritoneal dialysis patients versus healthy subjects.
    Delarue J; Maingourd C; Couet C; Vidal S; Bagros P; Lamisse F
    Perit Dial Int; 1998; 18(5):505-11. PubMed ID: 9848629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro effects of amino-acid-based versus glucose-based continuous ambulatory peritoneal dialysis fluids on peritoneal macrophage function.
    Schenk U; Kiefer T; Hübel E; Weber J; Mettang T; Passlick-Deetjen J; Kuhlmann U
    Nephron; 1994; 68(3):338-46. PubMed ID: 7838257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A longitudinal study of the effects of amino acid-based CAPD fluid on amino acid retention and protein losses.
    Young GA; Dibble JB; Taylor AE; Kendall S; Brownjohn AM
    Nephrol Dial Transplant; 1989; 4(10):900-5. PubMed ID: 2515496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peritoneal dialysis with solutions containing amino acids plus glucose promotes protein synthesis during oral feeding.
    Tjiong HL; Rietveld T; Wattimena JL; van den Berg JW; Kahriman D; van der Steen J; Hop WC; Swart R; Fieren MW
    Clin J Am Soc Nephrol; 2007 Jan; 2(1):74-80. PubMed ID: 17699390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mathematical modeling of the glucose-insulin system during peritoneal dialysis with glucose-based fluids.
    Galach M; Waniewski J; Axelsson J; Heimburger O; Werynski A; Lindholm B
    ASAIO J; 2011; 57(1):41-7. PubMed ID: 21057307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The determination of insulin sensitivity in hemodialysis and continuous ambulatory peritoneal dialysis in nondiabetic patients with end-stage renal disease.
    Tuzcu A; Bahceci M; Yilmaz ME; Turgut C; Kara IH
    Saudi Med J; 2005 May; 26(5):786-91. PubMed ID: 15951871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of peritoneal dialysis solution type on serum lipid levels in end-stage renal disease.
    Kanbay M; Bavbek N; Delibasi T; Koca C; Kaya A; Altay M; Akcay A; Duranay M; Yigitoglu R
    Ren Fail; 2007; 29(3):309-13. PubMed ID: 17497445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of an L-carnitine-containing peritoneal dialysate on insulin sensitivity in patients treated with CAPD: a 4-month, prospective, multicenter randomized trial.
    Bonomini M; Di Liberato L; Del Rosso G; Stingone A; Marinangeli G; Consoli A; Bertoli S; De Vecchi A; Bosi E; Russo R; Corciulo R; Gesualdo L; Giorgino F; Cerasoli P; Di Castelnuovo A; Monaco MP; Shockley T; Rossi C; Arduini A
    Am J Kidney Dis; 2013 Nov; 62(5):929-38. PubMed ID: 23725973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Icodextrine and insulin resistance in continuous ambulatory peritoneal dialysis patients.
    Canbakan M; Sahin GM
    Ren Fail; 2007; 29(3):289-93. PubMed ID: 17497442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperinsulinism reduction associated with icodextrin treatment in continuous ambulatory peritoneal dialysis patients.
    Amici G; Orrasch M; Da Rin G; Bocci C
    Adv Perit Dial; 2001; 17():80-3. PubMed ID: 11510303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.